Pipeline
Compound
Indication
Exploratory
Lead Opt.
Non-clinical Dev.
Phase I
Phase II
Endometriosis
HMI-115
Androgenic Alopecia
Third Indication
Decoy Receptor Protein
Diabetic foot ulcer
Therapeutic Protein Therapy
Myocardial infarction
GPCR antagonist
Cancer Cachexia
Kinase Inhibitor
Kinase Inhibitor
Enzyme Inhibitor
Chemotherapy Toxicity
Kinase Inhibitor
ARDS/Sepsis
HMI-115
Exploratory
Lead Opt.
Non-clinical Dev.
Phase I
Phase II
Endometriosis
Androgenic Alopecia
Third Indication
Decoy Receptor Protein
Exploratory
Lead Opt.
Non-clinical Dev.
Phase I
Phase II
Diabetic foot ulcer
Therapeutic Protein Therapy
Exploratory
Lead Opt.
Non-clinical Dev.
Phase I
Phase II
Myocardial infarction
GPCR antagonist
Exploratory
Lead Opt.
Non-clinical Dev.
Phase I
Phase II
Cancer Cachexia
Kinase Inhibitor
Exploratory
Lead Opt.
Non-clinical Dev.
Phase I
Phase II
Kinase Inhibitor
Enzyme Inhibitor
Exploratory
Lead Opt.
Non-clinical Dev.
Phase I
Phase II
Chemotherapy Toxicity
Kinase Inhibitor
Exploratory
Lead Opt.
Non-clinical Dev.
Phase I
Phase II
ARDS/Sepsis
